Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma
Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma
批准号:
10608358
负责人:
Jose Alejandro Guevara-Patino
金额:
$40.78万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-18 至 2025-08-31
关键词:
AddressAffectAutoimmuneBloodCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCRISPR/Cas technologyCellsCellular StructuresComplexCytotoxic T-LymphocytesDataDevelopmentEngineeringEnsureFlow CytometryGene Expression ProfilingGenesGenetic EngineeringGenetic TranscriptionHomeHomingHumanImmunologyIndividualKnockout MiceMediatingMemoryMicroscopyMolecularMusPIK3CG geneParticipantPatientsPlayPrognostic FactorPropertyProteinsRegulatory ElementRepressionResearchResearch DesignResearch SupportRoleSignal TransductionSkinSkin CancerSumT cell differentiationT memory cellT-Cell ReceptorT-LymphocyteTechniquesTestingTissuesTranscription Factor AP-1Transgenic MiceVitiligoWestern BlottingWorkadaptive immunityautoreactive T cellcell motilitychemokine receptorchromatin immunoprecipitationclinical applicationdesignengineered T cellsgp100 Antigenhuman modelin vivoinnovationinsightmelanocytemelanomamigrationmouse modelmutantnovelpathogenpromoterreceptorrecruitsmall hairpin RNAtraffickingtranscription factortransplant modeltumor growth
中文摘要
摘要
在免疫学领域,T细胞迁移被认为对宿主的长期存活至关重要。然而,
参与的参与者和这个复杂网络中的机械关系仍有待完全建立,特别是
在白癜风和黑色素瘤的背景下。我们对T细胞迁移特性和起始时间的了解可能有助于
找到临床上适用于白癜风和黑色素瘤的治疗方法。基于新的初步数据,我们建议研究
NKG 2D信号传导作为T细胞运输的贡献者。这项研究的科学前提来自我们的工作
这表明NKG 2D的缺乏降低了T细胞的迁移和CCR 4的表达。我们假设NKG 2D
通过精细调节的DAP 10 PI 3 K/Grb 2信号传导控制CD 8 T细胞运输(因为NKG 2D本身不能发出信号
使用DAP 10 PI 3 K/Grb 2作为信号转导衔接子),其控制CCR 4的表达。该提案将确定基本的
NKG 2D-DAP 10 PI 3 K和-DAP 10 Grb 2在CD 8 T细胞运输和CCR 4表达调控中的作用。这里我们将
利用人类和小鼠模型进行实验测试。
SA 1.确定控制NKG 2D-DAP 10 PI 3 K和/或-DAP 10 Grb 2的信号路径
CCR 4表达。
SA 2.确定NKG 2D-DAP 10 PI 3 K和/或-DAP 10 Grb 2的比贡献
CD 8 T细胞的皮肤运输中的信号传导。
英文摘要
Abstract
In the field of immunology, T cell migration is considered crucial for long-term host survival. However, the identity of the
players that participate and the mechanistic relationships in this complex network remain to be fully established, especially
in the context of vitiligo and melanoma. Our understanding of the T cell migratory properties and initiation ques may help
find clinically applicable treatments to vitiligo and melanoma. Based on novel preliminary data, we propose to study
NKG2D signaling as a contributor to T cell trafficking. The scientific premise of this study is derived from our work
demonstrating that lack of NKG2D reduces T cell tmigration and expression of CCR4. We hypothesize that NKG2D
controls CD8 T cell trafficking through a finely tuned DAP10PI3K/Grb2 signaling (as NKG2D cannot signal by itself instead
of using DAP10PI3K/Grb2 as signaling adaptor) that controls the expression of CCR4. This proposal will define the underlying
roles of NKG2D-DAP10PI3K and -DAP10Grb2 in CD8 T cell trafficking and the expression control of CCR4. Here we will
conduct experimental tests utilizing human and mouse models.
SA1. TO DETERMINE THE SIGNALING PATH FOR NKG2D-DAP10PI3K and/or -DAP10Grb2 THAT CONTROLS
CCR4 EXPRESSION.
SA2. TO DETERMINE THE SPECIFIC CONTRIBUTION OF NKG2D-DAP10PI3K and/or -DAP10Grb2
SIGNALING IN THE SKIN TRAFFIC OF CD8 T CELLS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
-
批准号:10448715
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2021
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
-
批准号:10363630
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2021
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells
-
批准号:10555239
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2021
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses
-
批准号:8918555
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2014
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation
-
批准号:8672173
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2014
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation
-
批准号:8909077
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2014
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation
-
批准号:9313795
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2014
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses
-
批准号:8756661
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2014
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Impact of AICD on TCR Transduced T Cells for Adoptive Immunotherapy
-
批准号:8555360
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2011
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Disparate suppression of naive effector and memory T cells in tumor-bearing hosts
-
批准号:7537204
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2008
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
Disparate suppression of naive effector and memory T cells in tumor-bearing hosts
-
批准号:7386277
-
项目类别:
-
资助金额:$20.72万
-
财政年份:2008
-
负责人:Jose Alejandro Guevara-Patino
-
依托单位:
海外基金